With a checkered history of misconduct, how will psychedelic-assisted therapists be held accountable in the emerging legal field?

Since COMPASS Pathways filed for a controversial psilocybin patent in 2018, Usona Institute has consistently placed its research findings in the public domain.

As technology and psychedelics turn to mental health, we’ll likely see a future where we are treated based on our digital biomarkers, and sold mental health services based on the personal data we surrender.

If someone overdoses from heroin or opiate drugs and has to be revived by paramedics or police with naloxone, they will be charged with “inducing panic.”

What if honest drug education, harm reduction, long term integration, and acknowledging risks, took the place of propaganda?

Last Week Tonight joined a long and growing list of media outlets that have added fuel to the hype of psychedelic medicalization. By omitting the potential risks and actual harms associated with psychedelic-assisted therapy, this messaging increases the risk to the public by presenting unrealistic expectations about experimental treatments.

How do you center the needs and perspectives of people of color in your activism—not because you want to fill a quota, but because the success of your work depends on it?

This is the first article in a series investigating the Church of Psilomethoxin (CoP), exploring the recent debate about the Church's sacrament and the people involved in promoting the Church and its claims.

Climate justice is racial justice, and we cannot achieve racial justice without ending the War on Drugs.

Proponents of drug prohibition provide reasons why alcoholic substances should continue to remain legal while substances like LSD should not. No persuasive arguments of that sort are anywhere to be found.